SCHEMBL5028437

SCHEMBL5028437

c1ccc(-n2c3ccncc3c3cc(-c4ccc5oc6c(-n7c8ccccc8c8cnccc87)cccc6c5c4)ccc32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAOA P21397 4/20 0.34
MAOB P27338 4/20 0.34
ACHE P22303 2/20 0.34
NPY5R Q15761 1/20 0.32
CYP2D6 P10635 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
RPS6KA5 O75582 1/20 0.31
SIRT2 Q8IXJ6 1/20 0.31
SIRT1 Q96EB6 1/20 0.31
PTGER4 P35408 1/20 0.31
REN P00797 1/20 0.31
PIK3CD O00329 1/20 0.30
PIK3CA P42336 1/20 0.30
PIK3CB P42338 1/20 0.30
PIK3CG P48736 1/20 0.30
BTK Q06187 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5028399 0.98 KDM4E (0.33) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL21481258 0.96 KDM4E (0.37) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL5028402 0.94 KDM4E (0.37) KDM4EATML3MBTL1NPY5RSIRT2
SCHEMBL21481257 0.92 MAOA (0.33) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL21481260 0.91 MAOA (0.33) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL10038508 0.90 KDM4E (0.45) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL21481239 0.90 KDM4E (0.37) KDM4EATML3MBTL1NPY5RPTGER4
SCHEMBL21481259 0.88 MAOA (0.32) MAOAMAOBACHENPY5R
SCHEMBL16482570 0.88 L3MBTL1 (0.43) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL10038498 0.88 L3MBTL1 (0.43) KDM4EATML3MBTL1SIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130119360-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME MERCK PATENT GMBH (DE) 2013-05-16 US disclosed
US-8367224-B2 Organic electroluminescence element, new compound for the same, display device and lighting device using the same KONICA MINOLTA HOLDINGS, INC. (JP) 2013-02-05 US disclosed
EP-2453496-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, NOVEL COMPOUND, LIGHTING DEVICE AND DISPLAY DEVICE Konica Minolta Holdings, Inc. (JP) 2012-05-16 EP disclosed
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2011-01-13 US disclosed
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110006670-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, NEW COMPOUND FOR THE SAME, DISPLAY DEVICE AND LIGHTING DEVICE USING THE SAME AOC2, AOC3, CDYL KDM4E 367/4885ATM 3194/4885L3MBTL1 1475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.